Dindyal Mandal
Overview
Explore the profile of Dindyal Mandal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kumar Singh R, Suryakanta U, Panigrahi B, Mishra S, Das S, Bhatta S, et al.
Luminescence
. 2024 Dec;
39(12):e70048.
PMID: 39660470
This study presents a mild, one-pot synthetic approach for the synthesis of multicolor, water soluble, photo luminescent CdS and CdSe quantum dots (QDs). To achieve this goal, cyclic peptides containing...
2.
Baral B, Panigrahi B, Kar A, Tulsiyan K, Suryakant U, Mandal D, et al.
Mol Ther Nucleic Acids
. 2023 Aug;
33:493-510.
PMID: 37583574
Self-assembled branched DNA (bDNA) nanomaterials have exhibited their functionality in various biomedical and diagnostic applications. However, the anionic cellular membrane has restricted the movement of bDNA nanostructures. Recently, amphiphilic peptides...
3.
Mandal D, Lohan S, Sajid M, Alhazza A, Tiwari R, Parang K, et al.
Pharmaceutics
. 2023 Feb;
15(2).
PMID: 36839988
RNA interference (RNAi) has drawn enormous attention as a powerful tool because of its capability to interfere with mRNA and protein production. However, designing a safe and efficient delivery system...
4.
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
Sajid M, Mandal D, El-Sayed N, Lohan S, Moreno J, Tiwari R
Pharmaceutics
. 2022 Apr;
14(4).
PMID: 35456715
Recent approvals of siRNA-based products motivated the scientific community to explore siRNA as a treatment option for several intractable ailments, especially cancer. The success of approved siRNA therapy requires a...
5.
Salehi D, Mozaffari S, Zoghebi K, Lohan S, Mandal D, Tiwari R, et al.
Cells
. 2022 Apr;
11(7).
PMID: 35406720
A series of cyclic peptides, [(DipR)(WR)], [(DipR)(WR)], [(DipR)(WR)], [(DipR)(WR)], and [DipR], and their linear counterparts containing arginine (R) as positively charged residues and tryptophan (W) or diphenylalanine (Dip) as hydrophobic...
6.
Mandal D, Mohammed E, Lohan S, Mandipoor P, Baradaran D, Tiwari R, et al.
Mol Pharm
. 2022 Mar;
19(5):1338-1355.
PMID: 35347995
RNA interference (RNAi) is a powerful tool capable of targeting virtually any protein without time-consuming and expensive drug development studies. However, due to obstacles facing efficient and safe delivery, RNAi-based...
7.
Panigrahi B, Kumar Singh R, Suryakant U, Mishra S, Potnis A, Jena A, et al.
Eur J Pharm Sci
. 2022 Jan;
171:106125.
PMID: 35033697
Vascular endothelial growth factor (VEGF) is considered as one of the vital growth factors for angiogenesis, which is primarily responsible for the progress and maintenance of new vascular network in...
8.
Lohan S, Mandal D, Choi W, Konshina A, Tiwari R, Efremov R, et al.
J Med Chem
. 2022 Jan;
65(1):665-687.
PMID: 34978443
We report the synthesis and antibacterial activities of a series of amphiphilic membrane-active peptides composed, in part, of various nongenetically coded hydrophobic amino acids. The lead cyclic peptides, and ,...
9.
Nasrolahi Shirazi A, Sajid M, Mandal D, Stickley D, Nagasawa S, Long J, et al.
Pharmaceuticals (Basel)
. 2021 Nov;
14(11).
PMID: 34832846
We have recently reported that a cyclic peptide containing five tryptophan, five arginine, and one cysteine amino acids [(WR)C], was able to produce peptide-capped gadolinium nanoparticles, [(WR)C]-GdNPs, in the range...
10.
Kumar S, Mandal D, El-Mowafi S, Mozaffari S, Tiwari R, Parang K
Pharmaceutics
. 2020 Sep;
12(9).
PMID: 32899170
The cellular delivery of cell-impermeable and water-insoluble molecules remains an ongoing challenge to overcome. Previously, we reported amphipathic cyclic peptides [WR] and [WR] consisting of alternate arginine and tryptophan residues...